Sun Pharmaceutical Industries has reported results for second quarter ended September 30, 2019.
The company has reported net profit of Rs 823.16 crore for the quarter under review as compared to net loss of Rs 806.07 crore for the same quarter in the previous year. Total income of the company increased by 20.80% at Rs 3,631.62 crore for Q2FY20 as compared Rs 3,006.24 crore for the corresponding quarter previous year.
On the consolidated basis, the company has reported net profit of Rs 1064.09 crore for the quarter under review as compared to net loss of Rs 269.60 crore for the same quarter in the previous year. Total income of the company increased by 14.21% at Rs 8,324.20 crore for Q2FY20 as compared Rs 7,288.78 crore for the corresponding quarter previous year.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1506.00 |
Dr. Reddys Lab | 6023.00 |
Cipla | 1394.50 |
Zydus Lifesciences | 933.15 |
Lupin | 1596.15 |
View more.. |